دوره 30، شماره 141 - ( 4-1401 )                   جلد 30 شماره 141 صفحات 339-333 | برگشت به فهرست نسخه ها


XML English Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Kadkhodaei B, Mosalaei A, Omidvari S, Ansari M, Mohammadianpanah M, Ahmadloo N, et al . Evaluation of the Long-Term Survival in Non-Metastatic Young Breast Cancer Patients in South of Iran. J Adv Med Biomed Res 2022; 30 (141) :333-339
URL: http://journal.zums.ac.ir/article-1-6452-fa.html
Evaluation of the Long-Term Survival in Non-Metastatic Young Breast Cancer Patients in South of Iran. Journal of Advances in Medical and Biomedical Research. 1401; 30 (141) :333-339

URL: http://journal.zums.ac.ir/article-1-6452-fa.html


چکیده:   (60590 مشاهده)

Background and Objective: The lack of breast cancer screening in young women leads to late disease diagnosis and worse outcomes in this age group. This study was designed to evaluate clinicopathological features and long-term outcomes of young breast cancer women in south of Iran.
Materials and Methods: This is a retrospective study of breast cancer patients who were pathologically diagnosed during 2005 to 2017. Data from 284 breast cancer patients aged 40 years or younger were included in this study. Demographic, clinicopathological properties as well as treatment modalities including type of surgery, adjuvant radiotherapy, and adjuvant or neoadjuvant chemotherapy were recorded and analyzed.
Results: Median age of the patients was 36 (range 23-40) years. After a median follow-up of 68 months, 21 patients had died due to the disease, 59 patients were alive with the disease, and 204 patients were alive without the disease. The univariate COX regression demonstrated that the disease -free survival (DFS) was significantly low in patients who had undergone breast conservation surgery (BCS) and also patients with higher stages, estrogen/progesterone-negative and human epidermal growth factor receptor 2-positive (ER-/PR-/HER2+) status. Low overall survival (OS) was also significantly associated with stage. According to multivariate COX regression, BCS, stages II, III and also young age were independent predictive factors for low DFS.
Conclusion: Given the aggressive features and worse outcome of young breast cancer patients, treatment remains tough and screening seems to be required at young age. Further studies are required to find best management and therapeutic protocols for these patients.

متن کامل [PDF 438 kb]   (31366 دریافت)    
نوع مطالعه: مقاله پژوهشی | موضوع مقاله: Clinical medicine
دریافت: 1399/12/10 | پذیرش: 1401/3/25 | انتشار: 1401/4/9

فهرست منابع
1. Merlo DF, Ceppi M, Filiberti R, et al. Breast cancer incidence trends in European women aged 20-39 years at diagnosis. Breast Cancer Res Treat. 2012;134(1):363-70. [DOI:10.1007/s10549-012-2031-7] [PMID]
2. Britt KL, Cuzick J, Phillips KA. Key steps for effective breast cancer prevention. Nat Rev Cancer.2020; 20:417-436. [DOI:10.1038/s41568-020-0266-x] [PMID]
3. Schaffar R, Bouchardy C, Chappuis PO, Bodmer A, Benhamou S, Rapiti E. A population-based cohort of young women diagnosed with breast cancer in Geneva, Switzerland. PloS one. 2019;14(9). e0222136. [DOI:10.1371/journal.pone.0222136] [PMID] [PMCID]
4. Fredholm H, Eaker S, Frisell J, Holmberg L, Fredriksson I, Lindman H. Breast cancer in young women: poor survival despite intensive treatment. PloS one. 2009;4(11). e7695. [DOI:10.1371/journal.pone.0007695] [PMID] [PMCID]
5. Fabiano V, Mando P, Rizzo M, et al. Breast cancer in young women presents with more aggressive pathologic characteristics: Retrospective Analysis From an Argentine National Database. JCO Glob Oncol. 2020;6: 639-646. [DOI:10.1200/JGO.19.00228] [PMID] [PMCID]
6. Silvera SAN, Jain M, Howe GR, Miller AB, Rohan TE. Energy balance and breast cancer risk: a prospective cohort study. Breast Cancer Res Treat 2006;97(1):97-106. [DOI:10.1007/s10549-005-9098-3] [PMID]
7. Laudisio D, Muscogiuri G, Barrea L, Savastano S, Colao A. Obesity and breast cancer in premenopausal women: Current evidence and future perspectives. Eur J Obstet Gyn R B. 2018; 230: 217-21. [DOI:10.1016/j.ejogrb.2018.03.050] [PMID]
8. Loibl S, Schmidt A, Gentilini O, et al. Breast cancer diagnosed during pregnancy: adapting recent advances in breast cancer care for pregnant patients. JAMA Oncol. 2015;1(8):1145-53. [DOI:10.1001/jamaoncol.2015.2413] [PMID]
9. Safi N, Saunders CH, Haven A, et al. Gestational breast cancer in New South Wales: A population-based linkage study of incidence, management, and outcomes. PloS One. 2021;16(1): e0245493. [DOI:10.1371/journal.pone.0245493] [PMID] [PMCID]
10. Noyes RD, Spanos JR WJ, Montague ED. Breast cancer in women aged 30 and under. Cancer. 1982;49(6):1302-7. https://doi.org/10.1002/1097-0142(19820315)49:6<1302::AID-CNCR2820490638>3.0.CO;2-0 [DOI:10.1002/1097-0142(19820315)49:63.0.CO;2-0]
11. Anderson BO, Petrek JA, Byrd DR, Senie RT, Borgen PI. Pregnancy influences breast cancer stage at diagnosis in women 30 years of age and younger. Ann Surg Oncol. 1996;3(2):204-11. [DOI:10.1007/BF02305802] [PMID]
12. Kurtz JM, Jacquemier J, Amalric R, et al. Why are local recurrences after breast-conserving therapy more frequent in younger patients? J Clin Oncol. 1990;8(4):591-8. [DOI:10.1200/JCO.1990.8.4.591] [PMID]
13. Voogd AC, Nielsen M, Peterse JL, et al. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol. 2001;19(6):1688-97. [DOI:10.1200/JCO.2001.19.6.1688] [PMID]
14. Lambertini M, Moore HCF, Leonard RCF, et al. Gonadotropin-releasing hormone agonists during chemotherapy for preservation of ovarian function and fertility in premenopausal patients with early breast cancer: A systematic review and meta-analysis of individual patient-level data. J Clin Oncol. 2018; 36(19): 1981-90. [DOI:10.1200/JCO.2018.78.0858] [PMID] [PMCID]
15. Yeo W, Lee HM, Chan A, et al. Risk factors and natural history of breast cancer in younger Chinese women. World J Clin Oncol .2014;5(5):1097. [DOI:10.5306/wjco.v5.i5.1097] [PMID] [PMCID]
16. Group EBCTC. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials. Lancet. 2011;378(9804):1707-16. [DOI:10.1016/S0140-6736(11)61629-2]
17. Han W, Kang SY. Relationship between age at diagnosis and outcome of premenopausal breast cancer: age less than 35 years is a reasonable cut-off for defining young age-onset breast cancer. Breast cancer Res Treat. 2010;119(1):193. [DOI:10.1007/s10549-009-0388-z] [PMID]
18. Anders CK, Johnson R, Litton J,et al. Breast cancer before age 40 years. Seminars in Oncology; 2009; pp 237-249. [DOI:10.1053/j.seminoncol.2009.03.001] [PMID] [PMCID]
19. Shannon C, Smith I. Breast cancer in adolescents and young women. Eur J Cancer 2003;39(18):2632-42. [DOI:10.1016/S0959-8049(03)00669-5]

بازنشر اطلاعات
Creative Commons License این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است.

کلیه حقوق این وب سایت متعلق به Journal of Advances in Medical and Biomedical Research می باشد.

طراحی و برنامه نویسی : یکتاوب افزار شرق

© 2024 CC BY-NC 4.0 | Journal of Advances in Medical and Biomedical Research

Designed & Developed by : Yektaweb